Potential immunological markers for diagnosis and therapeutic assessment of toxocariasis;Estudo de marcadores imunológicos para o diagnóstico e avaliação terapêutica da toxocaríase

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 53, Issue 2, 2011, Pages 61-65

  Rubinsky Elefant, Guita ^a   Hoshino Shimizu, Sumie ^a   Jacob, Cristina Miuki Abe ^a   Sanchez, Maria Carmen Arroyo ^a   Ferreira, Antonio Walter ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chemotherapy; Immunoblot assay; Immunoglobulin isotypes; Toxocariasis

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PARASITE ANTIGEN; PREDNISONE; TIABENDAZOLE; TOXOCARA EXCRETORY SECRETORY ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; HUMAN; IMMUNOBLOTTING; INFANT; MOLECULAR WEIGHT; PATIENT MONITORING; SCHOOL CHILD; TOXOCARA CANIS; TOXOCARIASIS;

EID: 79955909332     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/s0036-46652011000200001     Document Type: Article

References (24)

1. Badley JE, Grieve RB, Bowman DD, Glickman LT, Rockey JH. Analysis of Toxocara canis larval excretory-secretory antigens: physicochemical characterization and antibody recognition. J Parasitol. 1987;73:593-600.
2. Decoster A, Caron A, Darcy F, Capron A. IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet. 1988; 2:1104-7.
3. De Savigny DH, Voller A, Woodruff AW. Toxocariasis: serological diagnosis by enzyme immunoassay. J Clin Pathol. 1979;32:284-8.
4. Elefant GR, Shimizu SH, Sanchez MCA, Jacob CMA, Ferreira AW. A serological follow-up of toxocariasis patients after chemotherapy based on the detection of IgG, IgA and IgE antibodies by enzyme-linked immunosorbent assay. J Clin Lab Anal. 2006;20:164-72.
5. Gems D, Maizels RM. An abundantly expressed mucin-like protein from Toxocara canis infective larvae: the precursor of the larval surface coat glycoproteins. Proc Natl Acad Sci USA. 1996;93:1665-70.
6. Glickman LT, Schantz PM. Epidemiology and pathogenesis of zoonotic toxocariasis. Epidemiol Rev. 1981;3:230-50.
7. Hotez PJ, Wilkins PP. Toxocariasis: America's most common neglected infection of poverty and a helminthiasis of global importance? PLoS Negl Trop Dis. 2009;3:e400.
8. Ishida MMI, Rubinsky-Elefant G, Ferreira AW, Hoshino-Shimizu S, Vaz AJ. Helminth antigens (Taenia solium, Taenia crassiceps, Toxocara canis, Schistosoma mansoni and Echinococcus granulosus) and cross-reactivities in human infections and immunized animals. Acta Trop. 2003;89:73-84.
9. Jacob CMA, Pastorino AC, Peres BA, Melo EO, Okay Y, Oselka GW. Clinical and laboratorial features of visceral toxocariasis in infancy. Rev Inst Med Trop Sao Paulo. 1994;36:19-26.
10. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-5.
11. Magnaval JF, Fabre R, Maurières P, Charlet JP, De Larrard B. Application of the Western blotting procedure for the immunodiagnosis of human toxocariasis. Parasitol Res. 1991;77:697-702.
12. Magnaval JF, Glickman LT, Dorchies P, Morassin B. Highlights of human toxocariasis. Korean J Parasitol. 2001;39:1-11.
13. Magnaval JF, Malard L, Morassin B, Fabre R. Immunodiagnosis of ocular toxocariasis using Western-blot for the detection of specific anti-Toxocara IgG and CAP™ for the measurement of specific anti-Toxocara IgE. J Helminthol. 2002;76:335-9.
14. Maizels RM, Gems DH, Page AP. Synthesis and secretion of TES antigen from Toxocara canis infective larvae. In: Lewis JW, Maizels RM, editors. Toxocara and toxocariasis: clinical, epidemiological and molecular perspectives. London: British Society for Parasitology; 1993. p. 141-50.
15. Matta VLR, Hoshino-Shimizu S, Dietze R, Corbett CEP. Detection of specific antibody isotypes and subtypes before and after treatment of American visceral leishmaniasis. J Clin Lab Anal. 2000;14:5-12.
16. Morales OL, López MC, Nicholls RS, Agudelo C. Identification of Toxocara canis antigens by Western blot in experimentally infected rabbits. Rev Inst Med Trop Sao Paulo. 2002;44:213-6.
17. Nunes CM, Tundisi RN, Garcia JF, Heinemann MB, Ogassawara S, Richtzenhain LJ. Cross-reactions between Toxocara canis and Ascaris suum in the diagnosis of visceral larva migrans by Western-blotting technique. Rev Inst Med Top Sao Paulo. 1997;39:253-6.
18. Obwaller A, Jensen-Jarolim E, Auer H, Huber A, Kraft D, Aspöck H. Toxocara infestations in humans: symptomatic course of toxocarosis correlates significantly with levels of IgE/anti-IgE immune complexes. Parasite Immunol.1998;20:311-7.
19. Primavera KSC, Hoshino-Shimizu S, Umezawa ES, Peres BA, Manigot DA, Camargo ME. Immunoglobulin A antibodies to Trypanosoma cruzi antigens in digestive forms of Chagas' disease. J Clin Microbiol. 1988;26:2101-4.
20. Roldán WH, Espinoza YA. Evaluation of an enzyme-linked immunoelectrotransfer blot test for the confirmatory serodiagnosis of human toxocariasis. Mem Inst Oswaldo Cruz. 2009;104:411-8.
21. Schantz P. Toxocara larva migrans now. Am J Trop Med Hyg. 1989;41:21-34.
22. Smith HV. Antibody reactivity in human toxocariasis. In: Lewis JW, Maizels RM, editors. Toxocara and toxocariasis. Clinical, epidemiological and molecular perspectives. London: British Society for Parasitology; 1993. p. 91-109.
23. Smith H, Holland C, Taylor M, Magnaval JF, Schantz P, Maizels R. How common is human toxocariasis? Towards standardizing our knowledge. Trends Parasitol. 2009;25:182-8.
24. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76:4350-54.